State of Wisconsin Investment Board
ALGS icon

State of Wisconsin Investment Board’s Aligos Therapeutics ALGS Stock Holding History

State of Wisconsin Investment Board’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-972
Closed -$52K – 2794
2022
Q1 		$52K Hold
972
– – ﹤0.01% 2231
2021
Q4 		$288K Hold
972
– – ﹤0.01% 1990
2021
Q3 		$377K Buy
972
+143
+17% +$56.6K ﹤0.01% 1768
2021
Q2 		$422K Buy
+829
New +$528K ﹤0.01% 1724

Other funds holding ALGS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State of Wisconsin Investment Board's ALGS Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Aligos Therapeutics (ALGS) in Q2 2022, closing a stake of 972 shares — an estimated $52K sold.

State of Wisconsin Investment Board first reported a position in ALGS in Q2 2021 and held it in 4 quarters. The position peaked at $422K in Q2 2021. 59 funds tracked by Wall St. Rank hold ALGS as of Q2 2022.

  • State of Wisconsin Investment Board reported no remaining Aligos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 972 Aligos Therapeutics shares in Q2 2022, an estimated $52K.
  • State of Wisconsin Investment Board first reported a position in Aligos Therapeutics in Q2 2021 and held it in 4 quarters.
  • State of Wisconsin Investment Board's Aligos Therapeutics position peaked at $422K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.